Good piece in End Points this morning. They go into details around the 'winners & losers' from the traditional abstract drop that comes before the huge ASCO confab in Chicago on June 1st through June 5th this year. It is usually the biggest event for oncology every year with scores of companies presenting to eager analysts and investors. Based on the article and the pre-market trading action, the biggest winner this year was Loxo Oncology (LOXO). The biggest loser appears to be Jounce Therapeutices (JNCE).